According to a recent LinkedIn post from Doccla, founder Martin Ratz discussed on BBC Tech Life how a personal heart attack experience at age 44 exposed a gap in post-discharge patient monitoring. The post highlights his view that current systems shift from intensive in-hospital observation to minimal follow-up once patients return home.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post describes Doccla’s model as delivering hospital-level care at home through clinical-grade wearables, continuous data review by clinicians, and AI tools that surface early warning patterns with human oversight. The narrative emphasizes a transition from “reactive chaos” to personalized, proactive care using existing technology.
The post also references an estimate that 25–30% of patients currently in hospital may not need to be there if appropriate remote monitoring and virtual ward solutions were deployed. For investors, this framing suggests a sizable addressable market in reducing inpatient bed occupancy and enabling cost-efficient care pathways for health systems such as the NHS.
If Doccla can demonstrate clinical efficacy, regulatory compliance, and integration with public health providers, the approach could support recurring revenue models based on virtual ward deployments and service contracts. However, the post implicitly acknowledges that adoption speed depends on how quickly health systems move, highlighting execution risk around procurement cycles, reimbursement structures, and digital health funding priorities.

